A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

NCT07478822 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chongqing Claruvis Pharmaceutical Co., Ltd.